Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
As supply stabilized, manufacturers began striking direct deals with telehealth platforms to control access and expand affordability
The company has raised its 2024 sales forecast to between $2.74 billion and $2.77 billion, driven by strong uptake in polycythemia vera and GVHD
Toxicity mechanisms and bioavailability of copper to fish based on an adverse outcome pathway analysis
Prior authorization processes can extend 2-4 weeks, delaying treatment initiation for motivated patients
US$ 20.80
US$ 25.13
US$ 23.24
US$ 29.86
-1775582746855.png&w=3840&q=75)
US$ 27.53
US$ 23.40
